-transparent.png){kind=logo}
Data obtained from two multipurpose surveys of hospitalized patients were examined to determine the risk of nonfatal acute myocardial infarction in post-menopausal women 40 to 75 years of age in relation to use of estrogen-containing drugs. Eight (2.4 per cent) of 336 myocardial infarction patients and 330 (4.9 per cent) of 6730 reference patients were regular estrogen users (crude rate ratio, 0.47) at the time of hospitalization. After control for confounding variables -- among them, age, past history of myocardial in farction, angina, diabetes, and hypertension (alone or in combination) and cigarette smoking -- the summary point estimate of rate ratio was 0.97 with 95 per cent confidence limits of 0.48 and 1.95. Thus, there was no evidence of a statistically significant association between current regular use of estrogens and nonfatal acute myocardial infarction.
L Rosenberg, and
B Armstrong, and
H Jick
July 1968,
Rivista di ostetricia e ginecologia,
L Rosenberg, and
B Armstrong, and
H Jick
June 2007,
Human reproduction (Oxford, England),
L Rosenberg, and
B Armstrong, and
H Jick
December 2008,
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
L Rosenberg, and
B Armstrong, and
H Jick
July 1999,
Biological psychiatry,
L Rosenberg, and
B Armstrong, and
H Jick
January 1966,
L'Annee endocrinologique,
L Rosenberg, and
B Armstrong, and
H Jick
March 1999,
Maturitas,
L Rosenberg, and
B Armstrong, and
H Jick
November 2001,
The Journal of family practice,
L Rosenberg, and
B Armstrong, and
H Jick
July 1989,
Schweizerische medizinische Wochenschrift,
L Rosenberg, and
B Armstrong, and
H Jick
January 1979,
Revue medicale de Liege,
L Rosenberg, and
B Armstrong, and
H Jick
October 1985,
The Nurse practitioner,
